Evidence map›Paper›PMID 33284104›Full record

ArticleeLife2020

Cohesin mutations are synthetic lethal with stimulation of WNT signaling.

Chue Vin Chin, Jisha Antony, Sarada Ketharnathan, Anastasia Labudina, Gregory Gimenez, Kate M Parsons, Jinshu He, Amee J George, Maria Michela Pallotta, Antonio Musio and 4 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. STAG2 Regulates Homologous Recombination Repair and Sensitivity to ATM Inhibition.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Cohesin Mutations in Cancer: Emerging Therapeutic Targets.International journal of molecular sciences · 2021
    Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Chue Vin ChinDepartment of Pathology, Otago Medical School, University of Otago, Dunedin, New Zealand.
Jisha AntonyDepartment of Pathology, Otago Medical School, University of Otago, Dunedin, New Zealand.
Sarada KetharnathanDepartment of Pathology, Otago Medical School, University of Otago, Dunedin, New Zealand.
Anastasia LabudinaDepartment of Pathology, Otago Medical School, University of Otago, Dunedin, New Zealand.
Gregory GimenezDepartment of Pathology, Otago Medical School, University of Otago, Dunedin, New Zealand.
Kate M ParsonsThe John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
Jinshu HeThe John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
Amee J GeorgeThe John Curtin School of Medical Research, The Australian National University, Canberra, Australia.ORCID 0000-0002-0265-4476
Maria Michela PallottaIstituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche (CNR), Pisa, Italy.
Antonio MusioIstituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche (CNR), Pisa, Italy.ORCID 0000-0001-7701-6543
Antony BraithwaiteDepartment of Pathology, Otago Medical School, University of Otago, Dunedin, New Zealand.
Parry GuilfordDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
Ross D HannanThe John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
Julia A HorsfieldDepartment of Pathology, Otago Medical School, University of Otago, Dunedin, New Zealand.ORCID 0000-0002-9536-7790
Australian National University · AUUniversity of Auckland · NZUniversity of Otago · NZInstitute of Genetic and Biomedical Research · IT

Funding

Associazione Italiana per la Ricerca sul Cancro IG23284Health Research Council of New Zealand 15/229Health Research Council of New Zealand 19/415The Maurice Wilkins centre for Molecular Biodiscovery 3705733
6 · The paper itself

Abstract

Mutations in genes encoding subunits of the cohesin complex are common in several cancers, but may also expose druggable vulnerabilities. We generated isogenic MCF10A cell lines with deletion mutations of genes encoding cohesin subunits SMC3, RAD21, and STAG2 and screened for synthetic lethality with 3009 FDA-approved compounds. The screen identified several compounds that interfere with transcription, DNA damage repair and the cell cycle. Unexpectedly, one of the top 'hits' was a GSK3 inhibitor, an agonist of Wnt signaling. We show that sensitivity to GSK3 inhibition is likely due to stabilization of β-catenin in cohesin-mutant cells, and that Wnt-responsive gene expression is highly sensitized in

Indexed as

AnimalsCarcinogenesisCell Cycle ProteinsCell DivisionCell LineChromosomal Proteins, Non-HistoneCohesinsHumansSynthetic Lethal MutationsWnt Signaling PathwayZebrafishCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinscancer biologychromosomescohesindrug screengene expressionhumansynthetic lethaltranscriptionwnt signalingzebrafish

Identifiers

PMID33284104
PMCPMC7746233
OpenAlexW3112369885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.